Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 27 of Metagenomi Therapeutics, Inc.'s SEC filings and found 1 ATM program, 1 shelf registration and 1 S-1 registration on file for MGX. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 7, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
ACETAdicet Bio, Inc.
EDSAEdesa Biotech, Inc.
PMNProMIS Neurosciences, Inc.
FLNAFilana Therapeutics, Inc.
PLRZPolyrizon Ltd. Ordinary Shares
MBAIMBody AI Ltd.
AARDAardvark Therapeutics, Inc. Common Stock
EVAXEvaxion A/S American Depositary Share
RNAZTransCode Therapeutics, Inc.
ALGSAligos Therapeutics, Inc.
ABVCABVC BioPharma, Inc.
BCTXBriaCell Therapeutics Corp.
IXHLIncannex Healthcare Limited American Depositary Shares
CELUCelularity Inc.
NXTCNextCure, Inc.